Wedbush Initiates Coverage On IVERIC bio with Outperform Rating, Announces $13 Price Target

Wedbush analyst David Nierengarten initiates coverage on IVERIC bio (NASDAQ:ISEE) with a Outperform rating and a $13 price target.

Benzinga · 01/07/2020 13:17

Wedbush analyst David Nierengarten initiates coverage on IVERIC bio (NASDAQ:ISEE) with a Outperform rating and a $13 price target.